TNF and metastatic melanoma: In TICIMEL, which started in December 2017, 30 patients with metastatic melanoma are for the first time simultaneously treated with TNF blocking antibodies (Infliximab or Certolizumab), and ICI (Nivolumab and Ipilimumab).